|
Demographic characteristics
|
|
Age (years)
|
Mean (Min, max)
|
29.4 (12, 49)
|
29.2 (12,49)
|
32.5 (19, 45)
|
|
Length of time experiencing pelvic pain, years
|
Mean (Min–Max)
|
8.7 (0.5–27)
|
5.8 (1–16)
|
7.13 (1- 27)
|
|
Race, n (%)
|
White
|
14 (46.7%)
|
14 (46.7%)
|
9 (60.0%)
|
| |
Black/African American
|
12 (40.0%)
|
9 (30.0%)
|
3 (20.0%)
|
| |
Other
|
4 (13.3%)
|
7 (23.3%)
|
1 (6.7%)
|
| |
North African or Alaska Native
|
0 (0.0%)
|
0 (0.0%)
|
1 (6.7%)
|
| |
Multi-Racial
|
0 (0.0%)
|
0 (0.0%)
|
1 (6.7%)
|
|
Ethnicity, n (%)
|
Non-Hispanic or Latino
|
18 (60.0%)
|
21 (70.0%)
|
9 (60.0%)
|
| |
Hispanic or Latino
|
12 (40.0)
|
9 (30.0%)
|
6 (40.0%)
|
|
Highest level of education (adults only), n (%)
|
College or university degree
|
7 (23.3%)
|
6 (20.0%)
|
2 (13.3%)
|
| |
High school diploma or General Education Diploma
|
7 (23.3%)
|
4 (13.3%)
|
4 (26.7%)
|
| |
Some years of college
|
4 (13.3%)
|
6 (20.0%)
|
5 (33.3%)
|
| |
Certificate Program
|
2 (6.7%)
|
3 (10.0%)
|
3 (20.0%)
|
| |
Graduate or professional degree
|
0 (0.0%)
|
1 (6.7%)
|
1 (6.7%)
|
|
Work status, n (%)
|
Working full or part time
|
17 (56.7%)
|
19 (63.3%)
|
13 (86.7%)
|
| |
At school or student
|
10 (33.3%)
|
9 (30.0%)
|
1 (6.7%)
|
| |
Full time homemaker
|
3 (10.0%)
|
2 (6.7%)
|
1 (6.7%)
|
|
Clinical characteristics
|
|
Time since diagnosis*, years
|
Less than 5 years
|
15 (50%)
|
21 (70.0%)
|
8 (53.3%)
|
| |
6–10 years
|
6 (20%)
|
3 (10.0%)
|
6 (40.0%)
|
| |
Over 10 years
|
9 (30.0%)
|
6 (20.0%)
|
1 (6.7%)
|
|
Type of chronic pelvic pain, n (%)
|
Cyclic pain only
|
16 (53.3%)
|
19 (63.3%)
|
9 (60.0%)
|
| |
Cyclic and non-cyclic pain
|
14 (46.7%)
|
11 (36.7%)
|
6 (40.0%)
|
|
Severity of cyclic (menstrual) pelvic pain at screening using 0–10 Numerical Rating Scale (NRS)***, n
(%)
|
Mild (1–4)
|
7 (23.3%)
|
6 (20.0%)
|
5 (33.3%)
|
| |
Moderate (5–7)
|
12 (40.0%)
|
9 (30.0%)
|
5 (33.3%)
|
| |
Severe (8–10)
|
11 (36.7%)
|
15 (50.0%)
|
5 (33.3%)
|
| |
Mean (range)
|
6.53 (3–10)
|
7.27 (3–10)
|
6.07 (2–10)
|
|
Severity of non-cyclic (non-menstrual) pelvic pain at screening using 0–10 NRS***, n (%)
|
Mild (1–4)
|
10 (33.3%)
|
12 (40.0%)
|
4 (26.7%)
|
| |
Moderate (5–7)
|
13 (43.3%)
|
9 (30.0%)
|
7 (46.7%)
|
| |
Severe (8–10)
|
7 (23.3%)
|
9 (30.0%)
|
4 (26.7%)
|
| |
Mean (range)
|
5.6 (3–10)
|
6.13 (3–10)
|
5.87 (2–10)
|
|
Diagnostic procedure, n (%)
|
Surgical diagnosis
|
30 (100%)
|
20 (66.7%)
|
15 (100%)
|
| |
Clinically suspected endometriosis
|
0 (0.0%)
|
10 (33.3%)
|
0 (0.0%)
|
|
Hormonal therapy, n (%)
|
On hormonal therapy
|
15 (50.0%)
|
15 (50.0%)
|
9 (60.0%)
|
| |
Not on hormonal therapy
|
15 (50.0%)
|
15 (50.0%)
|
6 (40.0%)
|
|
Current treatment**, pharmacological (non-hormonal), n (%)
|
Nonsteroidal Anti-Inflammatory Drugs
|
25 (83.3%)
|
24 (80.0%)
|
12 (80.0%)
|
| |
Other pain medications (incl. Acetaminophen)
|
2 (6.7%)
|
15 (50.0%)
|
4 (26.7%)
|
| |
Opiate (incl. codeine, oxycodone)
|
3 (10%)
|
3 (10.0%)
|
1 (6.7%)
|
